Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Rinaldi

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
World Journal of Hepatology|January 2, 2018
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antiviralsViola Guardigni, Lorenzo Badia, Matteo Conti, et al.
IEEE Transactions on Circuits and Systems. I, Regular Papers : a Publication of the IEEE Circuits and Systems Society|September 26, 2022
A ±0.5dB, 6nW RSSI Circuit with RF Power-to-Digital Conversion Technique for Ultra-low Power IoT Radio ApplicationsAnkit Mittal, Nikita Mirchandani, Giuseppe Michetti, et al.
International Journal of Antimicrobial Agents|October 1, 2023
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumoniaMilo Gatti, Matteo Rinaldi, Paolo Gaibani, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 2024
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipientsMilo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Journal of Anesthesia, Analgesia and Critical Care|December 3, 2025
Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infectionsMilo Gatti, Pierantonio Grimaldi, Matteo Rinaldi, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2023
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Therapeutic Drug Monitoring|May 2, 2025
Utility of a TDM-Guided Expert Clinical Pharmacological Advice Program for Optimizing the Use of Novel Beta-Lactam/Beta-Lactamase Inhibitor Combinations and Cefiderocol in a Tertiary University Hospital: An Interim AnalysisMilo Gatti, Pier Giorgio Cojutti, Matteo Rinaldi, et al.
Journal of Perinatal Medicine|July 22, 2006
Four chamber view plus three-vessel and trachea view for a complete evaluation of the fetal heart during the second trimesterAntongiulio Del Bianco, Salvatore Russo, Nicola Lacerenza, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|August 12, 2009
Troponin in newborns and pediatric patientsMichele Correale, Loredana Nunno, Riccardo Ieva, et al.
Pharmaceutics|February 25, 2023
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill PatientsCarla Troisi, Pier Giorgio Cojutti, Matteo Rinaldi, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
World Journal of Hepatology|January 2, 2018
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antiviralsViola Guardigni, Lorenzo Badia, Matteo Conti, et al.
IEEE Transactions on Circuits and Systems. I, Regular Papers : a Publication of the IEEE Circuits and Systems Society|September 26, 2022
A ±0.5dB, 6nW RSSI Circuit with RF Power-to-Digital Conversion Technique for Ultra-low Power IoT Radio ApplicationsAnkit Mittal, Nikita Mirchandani, Giuseppe Michetti, et al.
International Journal of Antimicrobial Agents|October 1, 2023
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumoniaMilo Gatti, Matteo Rinaldi, Paolo Gaibani, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 2024
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipientsMilo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Journal of Anesthesia, Analgesia and Critical Care|December 3, 2025
Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infectionsMilo Gatti, Pierantonio Grimaldi, Matteo Rinaldi, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2023
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Therapeutic Drug Monitoring|May 2, 2025
Utility of a TDM-Guided Expert Clinical Pharmacological Advice Program for Optimizing the Use of Novel Beta-Lactam/Beta-Lactamase Inhibitor Combinations and Cefiderocol in a Tertiary University Hospital: An Interim AnalysisMilo Gatti, Pier Giorgio Cojutti, Matteo Rinaldi, et al.
Journal of Perinatal Medicine|July 22, 2006
Four chamber view plus three-vessel and trachea view for a complete evaluation of the fetal heart during the second trimesterAntongiulio Del Bianco, Salvatore Russo, Nicola Lacerenza, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|August 12, 2009
Troponin in newborns and pediatric patientsMichele Correale, Loredana Nunno, Riccardo Ieva, et al.
Pharmaceutics|February 25, 2023
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill PatientsCarla Troisi, Pier Giorgio Cojutti, Matteo Rinaldi, et al.
Pageof 17